Lv1
50 积分 2024-08-22 加入
Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice
1天前
待确认
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
7天前
已完结
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
14天前
已完结
Targeting the incretin system in obesity and type 2 diabetes mellitus
14天前
已完结
Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
21天前
已完结
Trend in prevalence, associated risk factors, and longitudinal outcomes of sarcopenia in China: A national cohort study
1个月前
已完结
Sarcopenia in youth
1个月前
已完结
Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
1个月前
已关闭
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
1个月前
已完结
Once-Weekly Semaglutide in Adults with Overweight or Obesity
1个月前
已完结
皖公网安备34019202002308
